Biotechnology CORRECTING AND REPLACING — Amicus Therapeutics Announces First Quarter 2022 Financial Results May 9, 2022
Biotechnology Axsome Therapeutics Completes U.S. Acquisition of Sunosi® (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea May 9, 2022
Biotechnology Allogene Therapeutics Named 2022 Bay Area “Best Place to Work” by San Francisco Business Times and Silicon Valley Business Journal May 9, 2022
Search
Biotechnology
